{"symbol":"ABT","fiscalQuarter":"Q1-2024","reportDate":"2024-04-17","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q1-2024","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 3.03%","keyNumbers":[{"metric":"EPS","actual":"$0.98","expected":"N/A","surprise":"+2.62%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS of $0.98, slightly beating expectations. However, the stock fell by 3.03% following the earnings release, indicating that investors may have had concerns despite the EPS beat. Without additional context from management commentary or guidance, the market's reaction reflects uncertainty about the company's future performance.","metaDescription":"Abbott Laboratories (ABT) Q1 2024 earnings: EPS beat by 2.62%. Stock down 3.03%. Full breakdown."}}